{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:10:49Z","timestamp":1791299449761,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001027","name":"Department of Health and Ageing, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2016.00321","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T22:56:27Z","timestamp":1484088987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Cerebral Blood Flow and A\u03b2-Amyloid Estimates by WARM Analysis of [11C]PiB Uptake Distinguish among and between Neurodegenerative Disorders and Aging"],"prefix":"10.3389","volume":"8","author":[{"given":"Anders B.","family":"Rodell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gjedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.neuroimage.2009.03.021","article-title":"Data-driven intensity normalization of PET group com- parison studies is superior to global mean normalization.","volume":"46","author":"Borghammer","year":"2009a","journal-title":"Neuroimage"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.neuroimage.2009.05.040","article-title":"Subcortical elevation of metabolism in Parkinson\u2019s disease\u2013a critical reappraisal in the context of global mean normalization.","volume":"47","author":"Borghammer","year":"2009b","journal-title":"Neuroimage"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-394816-8.00002-7","article-title":"Using Pitts- burgh compound B for in vivo PET imaging of fibrillar amyloid-beta.","volume":"64","author":"Cohen","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D inter-subject registration of MR volumetric data in standardized talairach space.","volume":"18","author":"Collins","year":"1994","journal-title":"J. Comput. Assist. Tomogr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria.","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"issue":"99","key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00099","article-title":"PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction.","volume":"5","author":"Fast","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/jcbfm.2012.118","article-title":"Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.","volume":"32","author":"Gejl","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"108","key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s disease, 6-month treatment with GLP-1 Analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial.","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fnene.2013.00002","article-title":"Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.","volume":"5","author":"Gejl","year":"2013","journal-title":"Front. Neuroenergetics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bcpt.12240","article-title":"At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.","volume":"115","author":"Gejl","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"70","key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00070","article-title":"Blood-brain transfer of pittsburgh compound B in humans.","volume":"5","author":"Gjedde","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"B14","article-title":"Symetric atlasing and model based segmentation: an application to the hippocampus in older adults","author":"Grabner","year":"2006","journal-title":"Medical Image Computing and Computer Assisted Intervention (MICCAI)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis.","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.bp.115.167569","article-title":"Alzheimer\u2019s disease: the amyloid hypothesis on trial.","volume":"208","author":"Harrison","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1468-1331.2000.00088.x","article-title":"Statistical maps of cerebral blood flow deficits in Alzheimer\u2019s disease.","volume":"7","author":"Johannsen","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/brain\/aws327","article-title":"Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease.","volume":"136(Pt 3)","author":"Lehmann","year":"2013","journal-title":"Brain Mar."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","article-title":"A probabilistic atlas and reference system for the human brain: international consortium for brain mapping (ICBM).","volume":"356","author":"Mazziotta","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders.","volume":"14","author":"Penzes","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome.","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"issue":"45","key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00045","article-title":"Washout allometric reference method (WARM) for parametric analysis of [(11)C]PIB in human brains.","volume":"5","author":"Rodell","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnene.2012.00008","article-title":"Low residual CBF variability in Alzheimer\u2019s disease after correction for CO(2) Effect.","volume":"4","author":"Rodell","year":"2012","journal-title":"Front Neuroenergetics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia.","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"212063","key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/212063","article-title":"Alzheimer\u2019s disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: difference in cut-off levels from thai experience.","volume":"2012","author":"Senanarong","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/jlcr.854","article-title":"A rapid one-step radiosynthesis of the \u03b2- amyloid imaging radiotracer N-methyl-[11C]2(40-methylaminophenyl)-6- hydroxybenzothiazole ([11C]- 6-OH-BTA-1).","volume":"47","author":"Wilson","year":"2004","journal-title":"J. Labelled Comp. Radiopharm."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T22:56:31Z","timestamp":1484088991000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":28,"URL":"https:\/\/doi.org\/10.3389\/fnagi.2016.00321","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}